SE422791B - Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner - Google Patents

Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner

Info

Publication number
SE422791B
SE422791B SE7413485A SE7413485A SE422791B SE 422791 B SE422791 B SE 422791B SE 7413485 A SE7413485 A SE 7413485A SE 7413485 A SE7413485 A SE 7413485A SE 422791 B SE422791 B SE 422791B
Authority
SE
Sweden
Prior art keywords
metoximethyl
benzomorphanes
furylmethyl
preparing
analogy procedure
Prior art date
Application number
SE7413485A
Other languages
English (en)
Swedish (sv)
Other versions
SE7413485L (zh
Inventor
H Merz
A Langbein
G Walther
K Stockhaus
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE7413485L publication Critical patent/SE7413485L/xx
Publication of SE422791B publication Critical patent/SE422791B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE7413485A 1973-10-27 1974-10-25 Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner SE422791B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732354002 DE2354002A1 (de) 1973-10-27 1973-10-27 Neue n-(methoxymethyl-furylmethyl)6,7-benzomorphane und -morphinane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SE7413485L SE7413485L (zh) 1975-04-28
SE422791B true SE422791B (sv) 1982-03-29

Family

ID=5896658

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7413485A SE422791B (sv) 1973-10-27 1974-10-25 Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner

Country Status (27)

Country Link
US (1) US3981874A (zh)
JP (1) JPS5738590B2 (zh)
AT (6) AT335634B (zh)
BE (1) BE821505A (zh)
BG (3) BG27903A3 (zh)
CA (1) CA1056377A (zh)
CH (6) CH609046A5 (zh)
CS (3) CS171195B2 (zh)
DD (1) DD115909A5 (zh)
DE (1) DE2354002A1 (zh)
DK (1) DK138325C (zh)
ES (6) ES431059A1 (zh)
FI (1) FI62079C (zh)
FR (1) FR2248838B1 (zh)
GB (1) GB1482552A (zh)
HU (1) HU176479B (zh)
IE (1) IE41528B1 (zh)
IL (1) IL45938A (zh)
NL (1) NL7413980A (zh)
NO (1) NO140859C (zh)
PH (1) PH11894A (zh)
PL (3) PL92053B1 (zh)
RO (5) RO65656A (zh)
SE (1) SE422791B (zh)
SU (6) SU511005A3 (zh)
YU (5) YU36951B (zh)
ZA (1) ZA746790B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1513961A (en) * 1975-02-25 1978-06-14 Acf Chemiefarma Nv 6,7-benzomorphans method for their preparation and intermediates
US4208523A (en) * 1978-11-30 1980-06-17 Sterling Drug Inc. 11-Lower-alkyl-, 11-phenyl-lower-alkyl- and 11-cyclo-lower-alkyl-lower-alkyl-hexahydro-2,6-methano-3-benzazocines
JP5451611B2 (ja) 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ,インコーポレイテッド 11β−ヒドロキシステロイドデヒドロゲナーゼ1のサイクリックインヒビター
CA2704628C (en) * 2007-11-16 2016-11-29 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2229368A1 (en) 2007-12-11 2010-09-22 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2009100872A1 (en) * 2008-02-12 2009-08-20 Boehringer Ingelheim International Gmbh Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2723039A1 (en) 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8592410B2 (en) 2008-05-01 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
MX2010011935A (es) 2008-05-01 2011-05-19 Vitae Pharmaceuticals Inc Inhibidores ciclicos de 11 beta-hidroxiesteroide deshidrogenasa 1.
CA2724214A1 (en) 2008-05-13 2009-11-19 Boehringer Ingelheim International Gmbh Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
EP2324017B1 (en) 2008-07-25 2014-12-31 Boehringer Ingelheim International GmbH INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
CA2730499A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
TWI531571B (zh) 2009-11-06 2016-05-01 維它藥物公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜芳基羰基衍生物
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
TWI537258B (zh) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
WO2013025664A1 (en) 2011-08-17 2013-02-21 Boehringer Ingelheim International Gmbh Indenopyridine derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632591A (en) * 1968-07-19 1972-01-04 Sterling Drug Inc 1 2 3 4 5 6 - hexahydro-3-(cycloaliphatic or cycloaliphatic 11-dimethyl-2 alkyl)-66-methano-3-benzazocines
US3833595A (en) * 1968-12-26 1974-09-03 Sumitomo Chemical Co 2-aroylalkyl benzomorphans
CS166803B2 (zh) * 1971-02-08 1976-03-29 Boehringer Sohn Ingelheim

Also Published As

Publication number Publication date
IL45938A (en) 1977-12-30
RO65657A (ro) 1980-06-15
CH609685A5 (zh) 1979-03-15
US3981874A (en) 1976-09-21
ATA828774A (de) 1976-07-15
ES431059A1 (es) 1976-10-16
IE41528B1 (en) 1980-01-30
YU36519B (en) 1984-02-29
SU508193A3 (ru) 1976-03-25
ZA746790B (en) 1976-06-30
ES431054A1 (es) 1976-10-16
PL92086B1 (zh) 1977-03-31
BG27903A3 (en) 1980-01-15
PH11894A (en) 1978-08-29
DD115909A5 (zh) 1975-10-20
CH609340A5 (zh) 1979-02-28
ES431056A1 (es) 1976-10-16
NO140859C (no) 1979-11-28
YU285674A (en) 1982-06-18
AT335631B (de) 1977-03-25
ATA828974A (de) 1976-08-15
IL45938A0 (en) 1974-12-31
CA1056377A (en) 1979-06-12
NL7413980A (nl) 1975-04-29
YU285274A (en) 1982-02-25
YU285474A (en) 1982-06-18
CH609686A5 (zh) 1979-03-15
YU36951B (en) 1984-08-31
DK559874A (zh) 1975-06-23
ATA828674A (de) 1976-07-15
SU512707A3 (ru) 1976-04-30
AT335633B (de) 1977-03-25
CH609047A5 (zh) 1979-02-15
YU36952B (en) 1984-08-31
CH609046A5 (zh) 1979-02-15
ES431058A1 (es) 1976-10-16
ATA828574A (de) 1976-07-15
DK138325B (da) 1978-08-14
IE41528L (en) 1975-04-27
NO140859B (no) 1979-08-20
SU511005A3 (ru) 1976-04-15
DK138325C (da) 1979-01-22
ATA829074A (de) 1976-07-15
FR2248838B1 (zh) 1977-11-04
SU508192A3 (ru) 1976-03-25
CS171196B2 (zh) 1976-10-29
NO743845L (zh) 1975-05-26
BG27901A3 (en) 1980-01-15
HU176479B (en) 1981-03-28
FI62079B (fi) 1982-07-30
ATA828874A (de) 1976-06-15
FR2248838A1 (zh) 1975-05-23
DE2354002A1 (de) 1975-05-07
RO65655A (ro) 1980-06-15
YU36949B (en) 1984-08-31
AT335634B (de) 1977-03-25
CS171195B2 (zh) 1976-10-29
AT335632B (de) 1977-03-25
ES431057A1 (es) 1976-10-16
PL92052B1 (zh) 1977-03-31
SU578870A3 (ru) 1977-10-30
RO65658A (fr) 1979-07-15
CS171194B2 (zh) 1976-10-29
YU285374A (en) 1982-06-18
PL92053B1 (zh) 1977-03-31
YU36950B (en) 1984-08-31
RO65659A (ro) 1980-06-15
YU285174A (en) 1982-06-18
JPS5071679A (zh) 1975-06-13
CH609048A5 (zh) 1979-02-15
FI62079C (fi) 1982-11-10
SU510999A3 (ru) 1976-04-15
AT336202B (de) 1977-04-25
JPS5738590B2 (zh) 1982-08-16
AT335076B (de) 1977-02-25
ES431055A1 (es) 1976-10-16
BE821505A (fr) 1975-04-25
SE7413485L (zh) 1975-04-28
RO65656A (ro) 1980-06-15
GB1482552A (en) 1977-08-10
FI314174A (zh) 1975-04-28
BG27902A3 (en) 1980-01-15

Similar Documents

Publication Publication Date Title
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE453667B (sv) Forfarande for framstellning av polyeterimider
SE422791B (sv) Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner
SE412389B (sv) Forfarande for framstellning av 1-ftalazon-derivat.
SE421919B (sv) Forfarande for framstellning av 2-tetrahydrofurfuryl-6,7-bensomorfaner
SE417197B (sv) Analogiforfarande for framstellning av fenyletylaminderivat
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
SE422581B (sv) Analogiforfarande for framstellning av n-substituerade 3-hydroxi-8-oxamorfinaner
SE7508074L (sv) Forfarande for framstellning av stilbenderivat.
SE420098B (sv) Forfarande for framstellning av linkomycinderivat
NO151585C (no) Fremgangsmaate for fremstilling 6-deoksyoksytetracyklin
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
DK143804C (da) Analogifremgangsmaade til fremstilling af ergopeptinderivater
SE421313B (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE7408978L (sv) Forfarande for framstellning av ny heterocykliska foreningar.
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
FI55498B (fi) Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
SE415100B (sv) Forfarande for framstellning av kinuklidin-kinolinderivat
TR18287A (tr) Triasetonamin hazirlamaya mahsus usul
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
SE417966B (sv) Forfarande for framstellning av pyrimidinoaminometyl-ergolinderivat